Neoadjuvant anlotinib/sintilimab plus chemotherapy in triple-negative breast cancer (NeoSACT): Phase 2 trialLiulu Zhang, Kun Wang, Lu Yang et al.|Cell Reports Medicine|2025Cited by 9
Single-cell RNA sequencing elucidates cellular plasticity in esophageal small cell carcinoma following chemotherapy treatmentQinkai Zhang, Dongyang Yang, Xinyue Wang et al.|Frontiers in Genetics|2025Cited by 4
Abstract PO1-28-08: The Efficacy and Safety Results of Neoadjuvant Phase II study of Anlotinib plus Sintilimab Combined with Chemotherapy in Triple-negative Breast Cancer (NeoSACT)Liulu Zhang, Kun Wang, Hongfei Gao et al.|Cancer Research|2024Cited by 1